Tawil R - Search Results

1

Diagnostic odyssey of patients with myotonic dystrophy.

Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP, Tawil R, Thornton CA, Moxley RT 3rd. Hilbert JE, et al. Among authors: tawil r. J Neurol. 2013 Oct;260(10):2497-504. doi: 10.1007/s00415-013-6993-0. Epub 2013 Jun 27. J Neurol. 2013. PMID: 23807151 Free PMC article.

2

Scapuloperoneal syndromes. Absence of linkage to the 4q35 FSHD locus.

Tawil R, Myers GJ, Weiffenbach B, Griggs RC. Tawil R, et al. Arch Neurol. 1995 Nov;52(11):1069-72. doi: 10.1001/archneur.1995.00540350055017. Arch Neurol. 1995. PMID: 7487558

3

Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation. FSH-DY Group.

Griggs RC, Tawil R, McDermott M, Forrester J, Figlewicz D, Weiffenbach B. Griggs RC, et al. Among authors: tawil r. Muscle Nerve Suppl. 1995;2:S50-5. Muscle Nerve Suppl. 1995. PMID: 7739626

4

Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Personius KE, Pandya S, King WM, Tawil R, McDermott MP. Personius KE, et al. Among authors: tawil r. Phys Ther. 1994 Mar;74(3):253-63. doi: 10.1093/ptj/74.3.253. Phys Ther. 1994. PMID: 8115459

5

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group.

Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC. Tawil R, et al. Neurology. 1994 Mar;44(3 Pt 1):442-6. doi: 10.1212/wnl.44.3_part_1.442. Neurology. 1994. PMID: 8145913

6

Acetazolamide-induced nephrolithiasis: implications for treatment of neuromuscular disorders.

Tawil R, Moxley RT 3rd, Griggs RC. Tawil R, et al. Neurology. 1993 Jun;43(6):1105-6. doi: 10.1212/wnl.43.6.1105. Neurology. 1993. PMID: 8170551

7

Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic cases.

Griggs RC, Tawil R, Storvick D, Mendell JR, Altherr MR. Griggs RC, et al. Among authors: tawil r. Neurology. 1993 Nov;43(11):2369-72. doi: 10.1212/wnl.43.11.2369. Neurology. 1993. PMID: 8232958

8

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.

Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D. Tawil R, et al. Ann Neurol. 1996 Jun;39(6):744-8. doi: 10.1002/ana.410390610. Ann Neurol. 1996. PMID: 8651646

9

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC. Tawil R, et al. Neurology. 1997 Jan;48(1):46-9. doi: 10.1212/wnl.48.1.46. Neurology. 1997. PMID: 9008492

10

Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium.

Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B. Tawil R, et al. Ann Neurol. 1998 Mar;43(3):279-82. doi: 10.1002/ana.410430303. Ann Neurol. 1998. PMID: 9506542 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters